Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients

by Cattin, Sarah, Fellay, Benoît, Pradervand, Sylvain, Trojan, Andreas, Ruhstaller, Thomas, Rüegg, Curzio, Fürstenberger, Gregor
Published 2016